跳转至内容
Merck
CN

B0149

酸性蓝83

Dye content ~50 %, Powder

别名:

Coomassie 亮蓝R, 亮吲哚蓝蛋白 6B, 酸性蓝 83

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C45H44N3NaO7S2
化学文摘社编号:
分子量:
825.97
UNSPSC Code:
12171500
NACRES:
NA.47
PubChem Substance ID:
EC Number:
228-060-5
MDL number:
Beilstein/REAXYS Number:
5718025
Colour Index Number:
42660
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

酸性蓝83, Dye content ~50 %, Technical grade

Quality Level

form

powder

composition

Dye content, ~50%

technique(s)

microbe id | staining: suitable

solubility

H2O: 10 mg/mL

suitability

suitable for detection of protein bands following electrophoresis.

application(s)

diagnostic assay manufacturing
hematology
histology

storage temp.

room temp

SMILES string

[Na+].CCOc1ccc(Nc2ccc(cc2)C(\c3ccc(cc3)N(CC)Cc4cccc(c4)S([O-])(=O)=O)=C5\C=C/C(C=C5)=[N+](\CC)Cc6cccc(c6)S([O-])(=O)=O)cc1

InChI

1S/C45H45N3O7S2.Na/c1-4-47(31-33-9-7-11-43(29-33)56(49,50)51)40-23-15-36(16-24-40)45(35-13-19-38(20-14-35)46-39-21-27-42(28-22-39)55-6-3)37-17-25-41(26-18-37)48(5-2)32-34-10-8-12-44(30-34)57(52,53)54;/h7-30H,4-6,31-32H2,1-3H3,(H2,49,50,51,52,53,54);/q;+1/p-1

InChI key

NKLPQNGYXWVELD-UHFFFAOYSA-M

General description

亮蓝R(C.l.42660)是一种三氨基三芳基甲烷染料,其中两个氨基被苄基化,一个氨基被苯基化。它也被称为亮吲哚菁6B和考马斯蓝R250。

Application

亮蓝R已广泛用于十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)后的蛋白条带检测。其他应用包括:
  • 用作环氧树脂包埋组织切片蛋白染色剂
  • 定量显微密度测定切片内的蛋白质
  • 染色单体、肌动蛋白微丝,神经突和精子顶体显影。
电泳后检测蛋白条带。

Legal Information



Still not finding the right product?

Explore all of our products under 酸性蓝83


存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning.
Donato M, et al.
Experimental Physiology, 95, 274-281 (2010)
Effect of Flammulina velutipes on spent-hen breast meat tenderization.
Kang GH, et al.
Poultry Science, 91, 232-236 (2012)
Rozanne Arulanandam et al.
Communications biology, 3(1), 254-254 (2020-05-24)
We have demonstrated that microtubule destabilizing agents (MDAs) can sensitize tumors to oncolytic vesicular stomatitis virus (VSVΔ51) in various preclinical models of cancer. The clinically approved T-DM1 (Kadcyla®) is an antibody-drug conjugate consisting of HER2-targeting trastuzumab linked to the potent



全球贸易项目编号

货号GTIN
B0149-25G04061833419519
B0149-100G04061833419502
B0149-500G04061832340043
B0149-5G04061833419526